等待开盘 06-03 09:30:00 美东时间
-1.020
-1.18%
Legence (NASDAQ: LGN) shares reversed Thursday, turning lower despite Q1 revenue beat, above-estimate Q2 guidance and raised FY26 outlook.
05-14 22:23
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Legence (NASDAQ:LGN) raises FY2026 sales outlook from $3.700 billion-$3.900 billion to $4.100 billion-$4.300 billion vs $3.886 billion estimate.
05-14 19:05
Stock market mixed on Trump comments and Iran drafting monitoring protocol for Strait of Hormuz. Benzinga's Analyst Ratings API provides top analyst picks and their accuracy to help traders beat the market.
04-06 18:01
Legence Corp. reported mixed Q4 results, with earnings missing estimates but sales beating expectations. FY2026 sales guidance also raised.
03-30 23:23
Legence (NASDAQ:LGN) raises FY2026 sales outlook from $3.500 billion-$3.700 billion to $3.700 billion-$3.900 billion.
03-27 19:34
Companies Reporting Before The Bell • Instil Bio (NASDAQ:TIL) is expected to re...
03-27 19:11
Legence (NASDAQ:LGN) sees Q1 sales of $925.000 million-$950.000 million vs $724.841 million analyst estimate.
03-27 19:04
Legence (NASDAQ:LGN) sees FY2026 sales of $2.650 billion-$2.850 billion vs $2.631 billion analyst estimate.
2025-11-14 20:16